Historic and (potential) future Development of Lepidico, page-2

@dufhaste Thanks for taking the time to prepare a MC chart. There is a lot of discussion about the SP, whereas the MC is arguably a more important metric. I have wanted to see a chart of MC vs time to re-focus the SP discussion.

If you can update and re-post your chart at each milestone event, that will be helpful. Regarding outstanding options, it would be informative if you added a separate curve showing the fully diluted MC (ie, with options exercised) when the next updated is posted.

I will continue to track completion/slippage of milestones according to company announcements, and there should be some correlation.